№ files_lp_4_process_3_136948
File format: docx
Character count: 5807
File size: 367 KB
Mixed methods research article detailing the implementation, usability, and clinician perspectives of OxMIV in early psychosis intervention services, including quantitative assessment data and thematic interview analysis.
Year:
2025
Region / City:
United Kingdom
Topic:
Mental health, risk assessment
Document type:
Research study with supplementary materials
Institution:
Early Intervention in Psychosis Services
Authors:
Multiple clinicians and researchers
Target audience:
Mental health professionals
Study period:
12 months
Assessment tool:
Oxford Mental Illness and Violence (OxMIV)
Methodology:
Mixed methods (quantitative assessments and qualitative interviews)
Participants:
Clinicians and patients with carers
Supplementary materials:
OxMIV assessment data, clinician and patient characteristics, thematic analysis of interviews
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
2.1
Executive Lead:
Executive Director of Quality and Medical Leadership
Lead Author:
Principal Clinical Pharmacist
Approved Date:
14/11/2022
Approved By:
Drugs and Therapeutics Committee (DTC)
Ratified Date:
14/11/2022
Ratified By:
Drugs and Therapeutics Committee (DTC)
Issue Date:
08/02/2023
Expiry Date:
14/11/2025
Target Audience:
Clinical staff
Document Type:
Guidelines
Ratifying Committee:
Drugs and Therapeutics Committee (DTC)
Review Date:
14/11/2025
Summary of significant changes from previous version:
Minor amendments: References to Xeplion® LAI in the document changed to Paliperidone monthly LAI as generic version available
Purpose:
Provide clinical staff with clear guidance on prescribing antipsychotics for the management of psychosis / schizophrenia in adults.
Document Type:
Application form
Programme Name:
Living Well with Psychosis community funding call
Submission Method:
Online grants management system SmartSimple
Subject Area:
Severe enduring mental illness
Relevant Conditions:
Schizophrenia, bipolar disorder, post-traumatic stress disorder
Maximum Funding Duration:
18 months
Target Applicants:
Organisations working with people affected by severe enduring mental illness
Required Information:
Applicant details, project summary, funding request, organisational experience, governance involvement
Financial Information Requested:
Total funding requested and intended use of funds
Geographical Scope:
Boroughs specified by applicant
Decision-Making Criteria Reference:
Eligibility and scoring criteria
Year:
2016
Region / city:
United Kingdom
Topic:
Safety seeking behaviours, psychosis, anxiety
Document type:
Research article
Institution:
The University of Manchester, The Psychosis Research Unit, Greater Manchester West Mental Health NHS Foundation Trust
Author:
Sarah Tully, Adrian Wells, Anthony P. Morrison
Target audience:
Researchers, mental health professionals
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
Not specified
Region / city:
Not specified
Topic:
Mental health, psychosis
Document type:
Research article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, mental health professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
Contextual description:
Research article analyzing demographic characteristics and interview features used to identify individuals at clinical high risk for psychosis and community controls.
Year:
Not specified
Region / City:
Not specified
Topic:
Neurological Disorders, Psychiatry, Neuroimaging
Document Type:
Scientific Supplementary Figure
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Clinicians
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
A scientific supplement detailing post-hoc comparisons of FAT and FW between healthy controls, adolescent-onset schizophrenia, and adolescent-onset bipolar disorder with psychosis, using neuroimaging data.
Year:
2023
Region / City:
Global
Topic:
Mental Health, Psychosis, Schizophrenia
Document Type:
Research Protocol / Search Strategy
Organization:
N/A
Author:
N/A
Target Audience:
Researchers, Mental Health Professionals
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Keywords:
psychosis, schizophrenia, risk, treatment, early intervention, qualitative research, search strategy
Study title:
Prevalence of Pathogenic Antibodies in Psychosis 2 (PPiP2)
Principal Investigator:
Local PPiP2 researcher
Participant study ID:
[ID]
Date:
[Date]
Version:
[Version]
Year:
[Year]
Region / City:
[Region or city if mentioned]
Topic:
Medical Research, Psychiatric Studies
Document Type:
Consent Form
Institution:
University of Oxford
Author:
[Author(s) if available]
Target Audience:
Research Participants, Medical Professionals
Study Period:
[Study Period if mentioned]
Approval Date:
[Date of approval if mentioned]
Amendment Date:
[Date of amendments if mentioned]
Year:
2026
Organization:
The Royal College of Psychiatrists
Position:
Patient Representative or Carer Representative
Salary:
£140 per day
Contract Type:
3-Year Fixed Term
Location:
United Kingdom
Application Submission:
Email to [email protected]
Target Audience:
Applicants with relevant experience in patient or carer advocacy
Relevant Legislation:
Equality Act 2010
Member Programs:
Disability Confident employer scheme
Required Documents:
CV, Cover Letter, Diversity Monitoring Form
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Version:
1
Date:
April 2023
Study name:
TDA4Child study
Full title:
Evaluating the performance, feasibility, acceptability and impact of treatment-decision algorithms for pulmonary tuberculosis in children
Health condition:
Pulmonary tuberculosis in children
Intervention:
Treatment-decision algorithms for childhood tuberculosis
Study type:
Clinical research protocol
Study design:
Multisite evaluation study
Target population:
Children with presumptive pulmonary tuberculosis
Geographical scope:
Country-specific implementation
Guideline basis:
WHO consolidated guidelines on the management of tuberculosis in children and adolescents (2022)
Responsible organization:
World Health Organization
Leading programme:
Special Programme for Research and Training in Tropical Diseases (TDR)
Funding organizations:
WHO Global Tuberculosis Programme; UNOPS; United States Centers for Disease Control and Prevention
Ethical considerations included:
Ethical approval, informed consent, assent
Outcome measures:
Primary and secondary outcomes related to diagnostic and treatment decisions
Data components:
Data collection, management and statistical analysis plan
Period covered:
Study period as defined in the protocol
Country:
South Africa
Regulation:
Regulation 638
Year of regulation:
2018
Document type:
Administrative procedure
Subject:
Food safety compliance
Certificate:
Certificate of Acceptability (COA)
Responsible authority:
Ehlanzeni District Municipality Municipal Health Services
Related authority:
National Department of Health
Scope:
Food handling businesses
Target entities:
Restaurants, hawkers, retail shops, spaza shops, caterers, institutional kitchens, food transport vehicles
Inspection authority:
Environmental Health Practitioner
Legal basis:
Food safety legislation
Administrative requirements:
Zoning certificate, approved building plan, identity document of person in charge, proof of payment
Issuing condition:
Satisfactory inspection outcome
Enforcement measures:
Closure, fines, prohibition orders
Document type:
Guidance
Subject:
Documentation standards and evidence requirements
Scope:
Common types of financial and administrative documentation
Covered cost categories:
Personnel costs; Third-party invoices and contractual services; Credit card charges; Travel; Volunteer time; Volunteer meeting attendance; Donated professional services; Memoranda of Understanding
Acceptability levels:
Ideal; Acceptable; Not acceptable
Intended audience:
Program administrators, reviewers, and contractors
Issuing context:
Compliance and financial review
Format:
Narrative guidance with criteria descriptions
Year:
2023
Region / City:
Not specified
Topic:
Telehealth, Patient-Reported Outcomes
Document Type:
Research article
Institution:
Purdue University
Author:
Kaleb Emerson, Lyndsey N. Graham, Veronika Vozka, Riley Naughton, Katlyn Peek, Bridgette L. Kelleher
Target Audience:
Researchers, Healthcare Providers
Period of Action:
Ongoing (Project WellCAST)
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Not specified
Topic:
Health, Nutrition, Exercise
Document Type:
Research Study
Institution:
Not specified
Author:
Not specified
Target Audience:
Older pre-frail adults
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Title:
Evidence at-a-glance: Spotlight on Acceptability of DMPA-SC
Product:
DMPA-SC (subcutaneous depot medroxyprogesterone acetate)
Type of document:
Evidence summary brief
Thematic area:
Family planning and contraception
Focus:
Acceptability and user preferences
Geographic coverage:
Sub-Saharan Africa, Asia, Latin America, Europe, United Kingdom, United States
Countries referenced:
Democratic Republic of the Congo, Nepal, Senegal, Uganda, Malawi, Burkina Faso, Niger, India
Target population:
Women of reproductive age, including adolescents and young women
Key features:
Self-injection option, community-based distribution, room temperature stability (15°C–30°C), three-year shelf life
Effectiveness:
99% effective when administered correctly every three months
Price information:
US$0.85 per dose in standard 200-pack presentation for qualified buyers
Publisher / Organization:
PATH
Contact information:
[email protected]
Year:
2014
Region / Country:
England, UK
Topic:
Child development assessment
Document type:
Research report
Organization:
National Institute for Health Research Policy Research Programme
Authors:
Kendall S., Nash A., Braun A., Bastug G., Rougeaux E., Bedford H.
Target audience:
Health professionals, parents
Methods:
Mixed methods, interviews, focus groups
Key focus:
Acceptability and understanding of ASQ-3
Data collection period:
Not specified
Funding:
National Institute for Health Research Policy Research Programme
Context:
Healthy Child Programme two-year review
Qualitative sample size:
40 parents, 85 health professionals
Note:
Year
Organization / Institution:
World Health Organization
Year:
2018
Region / city:
North East England, UK
Topic:
Stroke rehabilitation, physical activity, sedentary behaviour
Document type:
Research protocol
Institution:
Newcastle University, Teesside University, Northumbria Healthcare NHS Foundation Trust
Authors:
Sarah A Moore, Leah Avery, Christopher IM Price, Darren Flynn
Target population:
Adult stroke survivors in community settings
Recruitment start date:
20.11.2018
Recruitment end date:
31.10.2019
Trial registration:
ISRCTN35516780
Keywords:
Stroke, physical activity, sedentary behaviour, behaviour change, feasibility, acceptability, fidelity
Version:
1
Date of protocol:
09.05.2018
Year:
2020
Region / City:
United States
Subject:
Nuclear Power Plant Regulations
Document Type:
Regulatory Guide
Organization / Institution:
U.S. Nuclear Regulatory Commission (NRC)
Author:
U.S. Nuclear Regulatory Commission (NRC)
Target Audience:
Reactor licensees and applicants
Period of Validity:
Ongoing
Approval Date:
2020
Amendment Date:
Not specified
Applicable Standards:
ASME BPV Code, Section XI
Related Documents:
RG 1.84, RG 1.192, RG 1.193
Regulatory Requirements:
10 CFR Part 50.55a